Biodesix, Inc. (BDSX)

USD 0.55

(-2.7%)

Net Debt Summary of Biodesix, Inc.

  • Biodesix, Inc.'s latest annual net debt in 2023 was 34.3 Million USD , up 405.28% from previous year.
  • Biodesix, Inc.'s latest quarterly net debt in 2024 Q3 was 30.55 Million USD , up 58.27% from previous quarter.
  • Biodesix, Inc. reported annual net debt of -11.23 Million USD in 2022, up 50.49% from previous year.
  • Biodesix, Inc. reported annual net debt of -22.7 Million USD in 2021, up 33.93% from previous year.
  • Biodesix, Inc. reported quarterly net debt of 19.3 Million USD for 2024 Q2, down -61.07% from previous quarter.
  • Biodesix, Inc. reported quarterly net debt of 49.58 Million USD for 2024 Q1, up 44.53% from previous quarter.

Annual Net Debt Chart of Biodesix, Inc. (2023 - 2018)

Historical Annual Net Debt of Biodesix, Inc. (2023 - 2018)

Year Net Debt Net Debt Growth
2023 34.3 Million USD 405.28%
2022 -11.23 Million USD 50.49%
2021 -22.7 Million USD 33.93%
2020 -34.36 Million USD -211.98%
2019 30.68 Million USD 78.56%
2018 17.18 Million USD 0.0%

Peer Net Debt Comparison of Biodesix, Inc.

Name Net Debt Net Debt Difference
Aclaris Therapeutics, Inc. -39.45 Million USD 186.959%
Applied DNA Sciences, Inc. -5.91 Million USD 680.094%
Aspira Women's Health Inc. -331 Thousand USD 10464.653%
BioNexus Gene Lab Corp. -5.79 Million USD 691.914%
bioAffinity Technologies, Inc. -1.24 Million USD 2860.169%
bioAffinity Technologies, Inc. -1.24 Million USD 2860.169%
Bionano Genomics, Inc. 34.88 Million USD 1.648%
CareDx, Inc -47.97 Million USD 171.509%
Check-Cap Ltd. -24.75 Million USD 238.581%
Castle Biosciences, Inc. -83.53 Million USD 141.071%
DarioHealth Corp. -7.54 Million USD 554.518%
Exact Sciences Corporation 1.94 Billion USD 98.24%
Fulgent Genetics, Inc. -82.56 Million USD 141.551%
Guardant Health, Inc. 220.22 Million USD 84.422%
ICON Public Limited Company 3.56 Billion USD 99.036%
IDEXX Laboratories, Inc. 493.94 Million USD 93.055%
Illumina, Inc. 1.21 Billion USD 97.174%
Intelligent Bio Solutions Inc. -5.43 Million USD 731.496%
iSpecimen Inc. -2.14 Million USD 1697.59%
Standard BioTools Inc. 46.5 Million USD 26.231%
MDxHealth SA 18.88 Million USD -81.663%
23andMe Holding Co. -141.37 Million USD 124.267%
Medpace Holdings, Inc. -103.32 Million USD 133.202%
Myriad Genetics, Inc. 88.1 Million USD 61.059%
Mainz Biomed B.V. 349.85 Thousand USD -9706.063%
ENDRA Life Sciences Inc. -2.43 Million USD 1506.31%
NeoGenomics, Inc. 269.19 Million USD 87.256%
Neogen Corporation 735.62 Million USD 95.336%
Inotiv, Inc. 382.14 Million USD 91.023%
Natera, Inc. -200.1 Million USD 117.145%
OpGen, Inc. 11.89 Million USD -188.491%
OPKO Health, Inc. 230.68 Million USD 85.128%
Psychemedics Corporation 334 Thousand USD -10171.557%
Prenetics Global Limited -43.33 Million USD 179.163%
Prenetics Global Limited -43.33 Million USD 179.163%
Precipio, Inc. -386 Thousand USD 8987.824%
Personalis, Inc. -8.02 Million USD 527.661%
RadNet, Inc. 1.14 Billion USD 97.013%
Sera Prognostics, Inc. -2.02 Million USD 1796.686%
Sotera Health Company 2.02 Billion USD 98.306%
Neuronetics, Inc. 2.79 Million USD -1126.564%
Star Equity Holdings, Inc. -15.33 Million USD 323.688%
Star Equity Holdings, Inc. -15.33 Million USD 323.688%
Trinity Biotech plc 63.73 Million USD 46.173%
T2 Biosystems, Inc. 33.8 Million USD -1.473%
Twist Bioscience Corporation -192.4 Million USD 117.831%
Exagen Inc. -12.77 Million USD 368.611%